Cargando…
Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1‐Wnt3a‐β‐Catenin Signaling Axis
BACKGROUND: Myocardial infarction (MI) is a cardiovascular disease with high morbidity and mortality. PI16 (peptidase inhibitor 16), as a secreted protein, is highly expressed in heart diseases such as heart failure. However, the functional role of PI16 in MI is unknown. This study aimed to investig...
Autores principales: | Wang, Luyang, Du, Anning, Lu, Yan, Zhao, Yunxi, Qiu, Ming, Su, Zhenyang, Shu, Huanyu, Shen, Hui, Sun, Wei, Kong, Xiangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227313/ https://www.ncbi.nlm.nih.gov/pubmed/37158154 http://dx.doi.org/10.1161/JAHA.122.028866 |
Ejemplares similares
-
Overexpression of peptidase inhibitor 16 attenuates angiotensin II–induced cardiac fibrosis via regulating HDAC1 of cardiac fibroblasts
por: Deng, Mengqing, et al.
Publicado: (2020) -
Transcription factor EB (TFEB) improves ventricular remodeling after myocardial infarction by inhibiting Wnt/β-catenin signaling pathway
por: Liu, Cong, et al.
Publicado: (2023) -
HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction
por: Zhu, Chenxi, et al.
Publicado: (2023) -
Sclerostin aggravates cardiac remodeling after myocardial infarction by inhibition of Wnt/β-catenin signaling pathway
por: Zheng, Shuxin, et al.
Publicado: (2022) -
POU2AF1 promotes MSCs adipogenesis by inhibiting HDAC1 expression
por: Wang, Yaqing, et al.
Publicado: (2021)